Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Furosemide-d5 is intended for use as an internal standard for the quantification of furosemide (Item No. 17273) by GC- or LC-MS. Furosemide is a loop diuretic and an inhibitor of the Na+/K+/2Cl- (NKCC) cotransporters, NKCC1 and NKCC2 (Kis = ~10 µM for both).1,2 In vivo, furosemide (0.1 mg/kg, p.o.) increases diuresis in beagle dogs.3 Furosemide (30 mg/kg) reduces ventricular collagen deposition and fibrosis in a rat model of dilated cardiomyopathy.4 It is also an inhibitor of carbonic anhydrase I (CAI), CAII, and CAIII (Kis = 0.052-0.065 µM) and organic ion transporter 1 (OAT1; Ki = 9.5 µM), as well as a GABAA receptor antagonist.5,6,7
WARNING This product is not for human or veterinary use.
1. Molecular cloning and functional expression of the K-
2. Physiology and pathophysiology of SLC12A1/2 transporters. Pflugers Arch. 466(1), 91-105 (2014).
3. Comparison between the effects of torsemide and furosemide on the reninangiotensin-
4. Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy. Biofactors 43(2), 187-194 (2017).
5. Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-
6. The novel process for the preparation of (1R,2R,3aS,9aS)-
7. Dihomogammalinolenic acid, but not eicosapentaenoic acid, activates washed human platelets. Biochim. Biophys. Acta 801(2), 265-276 (1984).